Literature DB >> 12427359

Gastrointestinal issues in children with rheumatologic disease.

Mirna Chehade1, Keith Benkov.   

Abstract

Distinctive arthritic patterns, some of which may parallel or even precede intestinal disease activity, are seen in inflammatory bowel disease. Some spondyloarthropathies are associated with transient ileocolic inflammation. Vasculitis frequently affects the gastrointestinal tract, predominantly manifesting with abdominal pain. In severe cases, intestinal ischemia and perforation may occur. Various arthritides are thought to be associated with other gastrointestinal diseases, such as celiac disease and hepatitis. The association between intestinal disease and arthritis is still being investigated. Interactions between the inflammatory intestinal cells and inflamed synovial cells have been demonstrated. Certain intestinal bacteria such as Klebsiella pneumoniae are suspected to play a role as triggers for the development of arthropathies. Genetic factors, especially human leukocyte antigen associations, are also being increasingly investigated for better characterization of the types of arthritis and possible prognostic implications. Various therapies, including nonsteroidal anti-inflammatory drugs, used to treat rheumatologic diseases have the potential to cause gastrointestinal complications.

Entities:  

Mesh:

Year:  2002        PMID: 12427359     DOI: 10.1007/s11926-002-0051-8

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  37 in total

1.  Human leukocyte subpopulations from inflamed gut bind to joint vasculature using distinct sets of adhesion molecules.

Authors:  M Salmi; S Jalkanen
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

2.  The prevalence of celiac disease autoantibodies in patients with systemic lupus erythematosus.

Authors:  M J Rensch; R Szyjkowski; R T Shaffer; S Fink; C Kopecky; L Grissmer; R Enzenhauer; S Kadakia
Journal:  Am J Gastroenterol       Date:  2001-04       Impact factor: 10.864

3.  Current approaches to reducing gastrointestinal toxicity of low-dose aspirin.

Authors:  A I Lanas
Journal:  Am J Med       Date:  2001-01-08       Impact factor: 4.965

Review 4.  Henoch-Schönlein purpura in children. Report of 100 patients and review of the literature.

Authors:  F T Saulsbury
Journal:  Medicine (Baltimore)       Date:  1999-11       Impact factor: 1.889

5.  Juvenile dermatomyositis: clinical profile and disease course in 25 patients.

Authors:  R Shehata; S al-Mayouf; A al-Dalaan; A al-Mazaid; S al-Balaa; S Bahabri
Journal:  Clin Exp Rheumatol       Date:  1999 Jan-Feb       Impact factor: 4.473

6.  Increased gut permeability in juvenile chronic arthritides. A multivariate analysis of the diagnostic parameters.

Authors:  P Picco; M Gattorno; N Marchese; S Vignola; M P Sormani; A Barabino; A Buoncompagni
Journal:  Clin Exp Rheumatol       Date:  2000 Nov-Dec       Impact factor: 4.473

7.  Polymorphism at codon 469 of the intercellular adhesion molecule-1 locus is associated with protection against severe gastrointestinal complications in Henoch-Schönlein purpura.

Authors:  M M Amoli; D L Mattey; M C Calviño; C Garcia-Porrua; W Thomson; A H Hajeer; W E Ollier; M A Gonzalez-Gay
Journal:  J Rheumatol       Date:  2001-05       Impact factor: 4.666

8.  Identical T-cell expansions in the colon mucosa and the synovium of a patient with enterogenic spondyloarthropathy.

Authors:  E May; E Märker-Hermann; B M Wittig; M Zeitz; K H Meyer zum Büschenfelde; R Duchmann
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

9.  Colonoscopic findings in intestinal Behçet's disease.

Authors:  C R Lee; W H Kim; Y S Cho; M H Kim; J H Kim; I S Park; D Bang
Journal:  Inflamm Bowel Dis       Date:  2001-08       Impact factor: 5.325

10.  Multiple intestinal stenoses and peripheral gangrene: a combination of two rare surgical complications in a child with Kawasaki disease.

Authors:  C Krohn; H Till; S Haraida; K Kurnik; R Boehm; R Grantzow; I Joppich
Journal:  J Pediatr Surg       Date:  2001-04       Impact factor: 2.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.